Sildenafil Tablet, Film Coated
Product Images NDC 50090-7963

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-7963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907963)

Sildenafil 25 mg film-coated tablet label from A-S Medication Solutions. The label lists Sildenafil USP with 25 mg strength, storage instructions to keep between 68 to 77 degrees Fahrenheit, and packaging details for 10 tablets. The label includes the NDC 50090-7963 and a note to see the package insert for dosage information.*

FDA Label Image

Figure 1 (Sildenafil Fig1)

A line graph presenting mean change from baseline in sitting systolic blood pressure over 24 hours post-dose in healthy volunteers. It compares Sildenafil 100 mg and placebo, with time on the x-axis and systolic blood pressure changes (mmHg) on the y-axis, showing distinct patterns for both treatments over the study period.*

FDA Label Image

Figure 2 (Sildenafil Fig2)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing change in systolic blood pressure (mmHg) over 8 hours post-dose. It compares two treatments: Doxazosin plus Placebo and Doxazosin plus Sildenafil 25 mg, with plotted data points linked by lines. The y-axis represents blood pressure change, and the x-axis shows time post-dose in hours.*

FDA Label Image

Figure 3 (Sildenafil Fig3)

Line graph showing mean standing systolic blood pressure change over 8 hours postdose. Two data series compare Doxazosin plus Placebo and Doxazosin plus Sildenafil 50 mg. The y-axis represents change in systolic blood pressure (mmHg) and the x-axis shows time in hours after dosing.*

FDA Label Image

Figure 4 (Sildenafil Fig4)

A line graph depicting the mean standing systolic blood pressure change from baseline over 8 hours after dosing. Two lines represent the groups: one with Doxazosin plus Sildenafil 100 mg and the other with Doxazosin plus placebo. The y-axis shows blood pressure change in mmHg and the x-axis shows time in hours after dosing.*

FDA Label Image

Figure 5 (Sildenafil Fig5)

A line graph showing mean Sildenafil plasma concentrations over time in healthy male volunteers after dosing with a commercial tablet. The x-axis represents time post dose in hours (0 to 24), and the y-axis shows plasma concentration in ng/mL (0 to 500). Concentrations peak shortly after dosing and then decline steadily over 24 hours.*

FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

This figure displays two bar charts comparing the effect of Sildenafil and placebo on maintenance of erection by baseline score. The vertical axis represents the percentage of patients at endpoint, while the horizontal axis shows baseline scores from 0 to 5, with multiple series indicated by a legend from 0 to 5. The top chart illustrates Sildenafil's effect, and the bottom chart illustrates placebo's effect, highlighting differences in patient response distribution at different baseline scores.*

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

A vertical bar chart titled 'Figure 7. Percentage of Patients Reporting an Improvement in Erections' displaying data for placebo and three sildenafil dosage groups (25 mg, 50 mg, 100 mg). The y-axis shows the percentage of patients reporting improvement, with sildenafil groups showing higher percentages compared to placebo.*

FDA Label Image

Structure (Sildenafil Str)

Chemical structure of sildenafil, depicting the molecular arrangement of atoms and bonds characteristic to the active ingredient in the pharmaceutical product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.